Searched over 200M research papers for "hyperbaric medicine"
10 papers analyzed
These studies suggest hyperbaric oxygen therapy (HBOT) may be effective for treating certain conditions like radiotherapy-induced lesions, diabetic foot ulcers, carbon monoxide poisoning, and wound healing, but its overall effectiveness and cost-effectiveness vary and require further research.
20 papers analyzed
Hyperbaric oxygen therapy (HBOT) involves breathing 100% oxygen in a pressurized chamber, typically at pressures above one atmosphere absolute. This therapy has been utilized for various medical conditions, leveraging the increased oxygen availability to promote healing and reduce morbidity and mortality in certain diseases.
Necrotizing fasciitis (NF) is a severe bacterial infection that destroys tissues under the skin. HBOT has been proposed as an adjunctive treatment to surgery and antibiotics for NF. However, a systematic review found no clinical trials meeting the criteria to conclusively support or refute the effectiveness of HBOT in managing NF, highlighting the need for high-quality clinical trials to define its role.
Radiotherapy can lead to late complications in normal tissues, limiting its effectiveness. HBOT has been used to treat these complications, particularly in the head, neck, pelvis, and nervous system. Evidence suggests that HBOT may be beneficial for conditions like mandibular osteoradionecrosis and haemorrhagic cystitis resistant to conventional treatments. However, the evidence is primarily from retrospective trials and case reports, indicating a need for more randomized trials.
Chronic wounds, such as diabetic foot ulcers and venous ulcers, pose significant health challenges. HBOT has shown promise in improving the healing of diabetic foot ulcers in the short term, although the benefits were not sustained in the long term. The therapy also demonstrated a significant reduction in ulcer area for venous ulcers at six weeks. Despite these findings, the trials had various design flaws, necessitating further research to confirm these benefits.
The design of sham-controlled trials in hyperbaric medicine is complex due to the need for adequate blinding and safety considerations. Strategies for sham treatments include using lower pressures or adjusted oxygen levels. Each approach has its advantages and disadvantages, and careful consideration is required to ensure the validity and safety of these trials.
HBOT is used in treating a variety of conditions, including carbon monoxide poisoning, arterial gas embolism, severe decompression sickness, and acute crush injuries. The therapy's efficacy in these conditions is supported by its ability to ameliorate tissue hypoxia, reduce inflammation, and mitigate ischemia-reperfusion injury. However, the treatment of critically ill patients with HBOT requires specialized equipment and personnel, emphasizing the need for careful risk-benefit analysis .
The therapeutic mechanisms of HBOT involve the generation of reactive oxygen and nitrogen species, which play a central role in cell signaling pathways. These mechanisms support the use of HBOT for refractory diabetic wound healing and radiation injuries. Further studies are needed to clarify its utility in other conditions and to refine patient selection criteria .
Hyperbaric oxygen therapy offers significant potential in treating various medical conditions, particularly those involving tissue hypoxia and chronic wounds. While evidence supports its use in certain scenarios, further high-quality research is essential to fully understand its efficacy and optimize its application in clinical practice.
Most relevant research papers on this topic